Literature DB >> 28441180

Neuropsychiatric adverse effects on dolutegravir: an emerging concern in Europe.

Amélie Menard1, Clementine Montagnac, Caroline Solas, Line Meddeb, Catherine Dhiver, Christelle Tomei, Isabelle Ravaux, Herve Tissot-Dupont, Saadia Mokhtari, Philippe Colson, Andreas Stein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28441180     DOI： 10.1097/QAD.0000000000001459

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  13 in total

1.  Integrase Inhibitors are Associated with Neuropsychiatric Symptoms in Women with HIV.

Authors:  Leah H Rubin; Jane A O'Halloran; Dionna W Williams; Yuliang Li; Kathryn C Fitzgerald; Raha Dastgheyb; Alexandra L Damron; Pauline M Maki; Amanda B Spence; Anjali Sharma; Deborah R Gustafson; Joel Milam; Kathleen M Weber; Adaora A Adimora; Igho Ofotokun; Margaret A Fischl; Deborah Konkle-Parker; Yanxun Xu
Journal:  J Neuroimmune Pharmacol       Date:  2022-02-17       Impact factor: 7.285

2.  Associations between Antiretroviral Drugs on Depressive Symptomatology in Homogenous Subgroups of Women with HIV.

Authors:  Dionna W Williams; Yuliang Li; Yanxun Xu; Leah H Rubin; Raha Dastgheyb; Kathryn C Fitzgerald; Pauline M Maki; Amanda B Spence; Deborah R Gustafson; Joel Milam; Anjali Sharma; Adaora A Adimora; Igho Ofotokun; Margaret A Fischl; Deborah Konkle-Parker; Kathleen M Weber
Journal:  J Neuroimmune Pharmacol       Date:  2020-01-13       Impact factor: 7.285

3.  Starting or Switching to an Integrase Inhibitor-Based Regimen Affects PTSD Symptoms in Women with HIV.

Authors:  Asante R Kamkwalala; Kunbo Wang; Yanxun Xu; Leah H Rubin; Jane O'Halloran; Dionna W Williams; Raha Dastgheyb; Kathryn C Fitzgerald; Amanda B Spence; Pauline M Maki; Deborah R Gustafson; Joel Milam; Anjali Sharma; Kathleen M Weber; Adaora A Adimora; Igho Ofotokun; Anandi N Sheth; Cecile D Lahiri; Margaret A Fischl; Deborah Konkle-Parker
Journal:  AIDS Behav       Date:  2021-01

4.  Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study.

Authors:  Delphine Sculier; Angèle Gayet-Ageron; Manuel Battegay; Matthias Cavassini; Jan Fehr; Cedric Hirzel; Patrick Schmid; Enos Bernasconi; Alexandra Calmy
Journal:  BMC Infect Dis       Date:  2017-07-06       Impact factor: 3.090

5.  Impact of UGT1A1 gene polymorphisms on plasma dolutegravir trough concentrations and neuropsychiatric adverse events in Japanese individuals infected with HIV-1.

Authors:  Hiroki Yagura; Dai Watanabe; Hiroyuki Kushida; Kosuke Tomishima; Hiroaki Togami; Atsushi Hirano; Masaaki Takahashi; Kazuyuki Hirota; Motoko Ikuma; Daisuke Kasai; Yasuharu Nishida; Munehiro Yoshino; Kunio Yamazaki; Tomoko Uehira; Takuma Shirasaka
Journal:  BMC Infect Dis       Date:  2017-09-16       Impact factor: 3.090

6.  Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients.

Authors:  Thomas Theo Brehm; Marleen Franz; Anja Hüfner; Sandra Hertling; Stefan Schmiedel; Olaf Degen; Benno Kreuels; Julian Schulze Zur Wiesch
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

7.  Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study.

Authors:  Rosario Palacios; M Mayorga; C M González-Domenech; C Hidalgo-Tenorio; C Gálvez; L Muñoz-Medina; J de la Torre; A Lozano; M Castaño; M Omar; Jesús Santos
Journal:  J Int Assoc Provid AIDS Care       Date:  2018 Jan-Dec

Review 8.  Antiretroviral Drugs Impact Autophagy with Toxic Outcomes.

Authors:  Laura Cheney; John M Barbaro; Joan W Berman
Journal:  Cells       Date:  2021-04-15       Impact factor: 6.600

9.  Neuropsychiatric outcomes before and after switching to dolutegravir-based therapy in an acute HIV cohort.

Authors:  Phillip Chan; Orlanda Goh; Eugène Kroon; Donn Colby; Carlo Sacdalan; Suteeraporn Pinyakorn; Peeriya Prueksakaew; Peter Reiss; Jintanat Ananworanich; Victor Valcour; Serena Spudich; Robert Paul
Journal:  AIDS Res Ther       Date:  2020-01-07       Impact factor: 2.250

Review 10.  Update on Adverse Effects of HIV Integrase Inhibitors.

Authors:  Agnieszka Kolakowska; Anaenza Freire Maresca; Intira Jeannie Collins; Johann Cailhol
Journal:  Curr Treat Options Infect Dis       Date:  2019-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.